Skip to Main Content

Author Details

Mar??a Arag??n
Primary Care Research Institute Jordi Gol, Universitat Autonoma de Barcelona
2016
26
13
PMIDPaper TitleJournal TitlePublished Year
37436441Drug utilization analysis of osteoporosis medications in seven European electronic health databases.Osteoporos Int2023
37724311Transforming the Information System for Research in Primary Care (SIDIAP) in Catalonia to the OMOP Common Data Model and Its Use for COVID-19 Research.Clin Epidemiol2023
37436441Drug utilization analysis of osteoporosis medications in seven European electronic health databases.Osteoporos Int2023
37724311Transforming the Information System for Research in Primary Care (SIDIAP) in Catalonia to the OMOP Common Data Model and Its Use for COVID-19 Research.Clin Epidemiol2023
34655476Cancer and the risk of coronavirus disease 2019 diagnosis, hospitalisation and death: A population-based multistate cohort study including 4â¿¿618â¿¿377 adults in Catalonia, Spain.Int J Cancer2022
35396302Impact of the COVID-19 pandemic on diagnoses of common mental health disorders in adults in Catalonia, Spain: a population-based cohort study.BMJ Open2022
35810806Air pollution and green spaces in relation to breast cancer risk among pre and postmenopausal women: A mega cohort from Catalonia.Environ Res2022
36418321Thrombosis and thrombocytopenia after vaccination against and infection with SARS-CoV-2 in Catalonia, Spain.Nat Commun2022
36188566International cohort study indicates no association between alpha-1 blockers and susceptibility to COVID-19 in benign prostatic hyperplasia patients.Front Pharmacol2022
35191114Background rates of five thrombosis with thrombocytopenia syndromes of special interest for COVID-19 vaccine safety surveillance: Incidence between 2017 and 2019 and patient profiles from 38.6 million people in six European countries.Pharmacoepidemiol Drug Saf2022
34655476Cancer and the risk of coronavirus disease 2019 diagnosis, hospitalisation and death: A population-based multistate cohort study including 4â¿¿618â¿¿377 adults in Catalonia, Spain.Int J Cancer2022
35094685Seek COVER: using a disease proxy to rapidly develop and validate a personalized risk calculator for COVID-19 outcomes in an international network.BMC Med Res Methodol2022
35396302Impact of the COVID-19 pandemic on diagnoses of common mental health disorders in adults in Catalonia, Spain: a population-based cohort study.BMJ Open2022
35810806Air pollution and green spaces in relation to breast cancer risk among pre and postmenopausal women: A mega cohort from Catalonia.Environ Res2022
36418321Thrombosis and thrombocytopenia after vaccination against and infection with SARS-CoV-2 in Catalonia, Spain.Nat Commun2022
36188566International cohort study indicates no association between alpha-1 blockers and susceptibility to COVID-19 in benign prostatic hyperplasia patients.Front Pharmacol2022
35191114Background rates of five thrombosis with thrombocytopenia syndromes of special interest for COVID-19 vaccine safety surveillance: Incidence between 2017 and 2019 and patient profiles from 38.6 million people in six European countries.Pharmacoepidemiol Drug Saf2022
35094685Seek COVER: using a disease proxy to rapidly develop and validate a personalized risk calculator for COVID-19 outcomes in an international network.BMC Med Res Methodol2022
33342753Renin-angiotensin system blockers and susceptibility to COVID-19: an international, open science, cohort analysis.Lancet Digit Health2021
34297116Body Mass Index and Risk of COVID-19 Diagnosis, Hospitalization, and Death: A Cohort Study of 2 524 926 Catalans.J Clin Endocrinol Metab2021
33536436The natural history of symptomatic COVID-19 during the first wave in Catalonia.Nat Commun2021
33791740Alpha-1 blockers and susceptibility to COVID-19 in benign prostate hyperplasia patients : an international cohort study.medRxiv2021
34272262Characteristics and Outcomes of Over 300,000 Patients with COVID-19 and History of Cancer in the United States and Spain.Cancer Epidemiol Biomarkers Prev2021
33661754Implementation of the COVID-19 Vulnerability Index Across an International Network of Health Care Data Sets: Collaborative External Validation Study.JMIR Med Inform2021
33342753Renin-angiotensin system blockers and susceptibility to COVID-19: an international, open science, cohort analysis.Lancet Digit Health2021
33118037Filling the gaps in the characterization of the clinical management of COVID-19: 30-day hospital admission and fatality rates in a cohort of 118â¿¿150 cases diagnosed in outpatient settings in Spain.Int J Epidemiol2021
33791740Alpha-1 blockers and susceptibility to COVID-19 in benign prostate hyperplasia patients : an international cohort study.medRxiv2021
33536436The natural history of symptomatic COVID-19 during the first wave in Catalonia.Nat Commun2021
33661754Implementation of the COVID-19 Vulnerability Index Across an International Network of Health Care Data Sets: Collaborative External Validation Study.JMIR Med Inform2021
34297116Body Mass Index and Risk of COVID-19 Diagnosis, Hospitalization, and Death: A Cohort Study of 2 524 926 Catalans.J Clin Endocrinol Metab2021
34272262Characteristics and Outcomes of Over 300,000 Patients with COVID-19 and History of Cancer in the United States and Spain.Cancer Epidemiol Biomarkers Prev2021
33118037Filling the gaps in the characterization of the clinical management of COVID-19: 30-day hospital admission and fatality rates in a cohort of 118â¿¿150 cases diagnosed in outpatient settings in Spain.Int J Epidemiol2021
32253492Incidence and Risk of Pneumococcal Pneumonia in Adults with Distinct Underlying Medical Conditions: A Population-Based Study.Lung2020
32253492Incidence and Risk of Pneumococcal Pneumonia in Adults with Distinct Underlying Medical Conditions: A Population-Based Study.Lung2020
32587982Renin-angiotensin system blockers and susceptibility to COVID-19: a multinational open science cohort study.medRxiv2020
33024121Deep phenotyping of 34,128 adult patients hospitalised with COVID-19 in an international network study.Nat Commun2020
32587982Renin-angiotensin system blockers and susceptibility to COVID-19: a multinational open science cohort study.medRxiv2020
33024121Deep phenotyping of 34,128 adult patients hospitalised with COVID-19 in an international network study.Nat Commun2020
31537841Statin use and the risk of colorectal cancer in a population-based electronic health records study.Sci Rep2019
31537841Statin use and the risk of colorectal cancer in a population-based electronic health records study.Sci Rep2019
31339099Pneumococcal vaccination coverages by age, sex and specific underlying risk conditions among middle-aged and older adults in Catalonia, Spain, 2017.Euro Surveill2019
31339099Pneumococcal vaccination coverages by age, sex and specific underlying risk conditions among middle-aged and older adults in Catalonia, Spain, 2017.Euro Surveill2019
29398161Analgesic Use and Risk for Acute Coronary Events in Patients With Osteoarthritis: A Population-based, Nested Case-control Study.Clin Ther2018
29398161Analgesic Use and Risk for Acute Coronary Events in Patients With Osteoarthritis: A Population-based, Nested Case-control Study.Clin Ther2018
29699550Evaluating clinical effectiveness of 13-valent pneumococcal conjugate vaccination against pneumonia among middle-aged and older adults in Catalonia: results from the EPIVAC cohort study.BMC Infect Dis2018
29373143[Antipneumococcal vaccination in Catalonian adults: Vaccine coverages and adequacy to distinct guideline recommendations].Aten Primaria2018
29699550Evaluating clinical effectiveness of 13-valent pneumococcal conjugate vaccination against pneumonia among middle-aged and older adults in Catalonia: results from the EPIVAC cohort study.BMC Infect Dis2018
29373143[Antipneumococcal vaccination in Catalonian adults: Vaccine coverages and adequacy to distinct guideline recommendations].Aten Primaria2018
28662648Prevalence of high, medium and low-risk medical conditions for pneumococcal vaccination in Catalonian middle-aged and older adults: a population-based study.BMC Public Health2017
28662648Prevalence of high, medium and low-risk medical conditions for pneumococcal vaccination in Catalonian middle-aged and older adults: a population-based study.BMC Public Health2017
  • 1 - 50 of 52

Recommended Authors

Mayo Clinic
Career Start Year 2018
Number of shared co-authors 0
Padua University Hospital
Career Start Year 2016
Number of shared co-authors 3
Vanderbilt University Medical Center
Career Start Year 2016
Number of shared co-authors 1
Institute for Biomedical Informatics, University of Pennsylvania
Career Start Year 2015
Number of shared co-authors 3
Instituto de Salud Carlos III
Career Start Year 2014
Number of shared co-authors 0
Hospital Clinico Universitario de Santiago de Compostela
Career Start Year 2014
Number of shared co-authors 0
Center for Clinical Investigation, Brigham and Women's Hospital
Career Start Year 2014
Number of shared co-authors 0
McGill University
Career Start Year 2014
Number of shared co-authors 0
University of California los angeles
Career Start Year 2013
Number of shared co-authors 0
US Centers for Disease Control and Prevention
Career Start Year 2013
Number of shared co-authors 0
Instituto de Investigacion Sanitaria de Santiago (IDIS)
Career Start Year 2013
Number of shared co-authors 0
Weizmann Institute of Science
Career Start Year 2012
Number of shared co-authors 0
Dalla Lana School of Public Health, University of Toronto
Career Start Year 2012
Number of shared co-authors 0
Centers for Disease Control and Prevention
Career Start Year 2011
Number of shared co-authors 1
Necker-Enfants Malades Hospital, Paris Cite University
Career Start Year 2008
Number of shared co-authors 1
Yale School of Public Health, Yale University
Career Start Year 2008
Number of shared co-authors 0
Harvard T.H. Chan School of Public Health
Career Start Year 2007
Number of shared co-authors 0
Vanderbilt University Medical Center
Career Start Year 2005
Number of shared co-authors 0
Karolinska Institutet
Career Start Year 2004
Number of shared co-authors 0
Karolinska Institutet
Career Start Year 2004
Number of shared co-authors 0
Centers for Disease Control and Prevention
Career Start Year 2004
Number of shared co-authors 0
Geneva Center for Emerging Viral Diseases, Geneva University Hospitals
Career Start Year 2003
Number of shared co-authors 0
Vanderbilt University Medical Center
Career Start Year 2000
Number of shared co-authors 0
Kaiser Permanente Washington Health Research Institute
Career Start Year 1998
Number of shared co-authors 3
Clalit Health Services, Ben Gurion University
Career Start Year 1998
Number of shared co-authors 0
Instituto Aragones de Ciencias de la Salud (IIS Aragon)
Career Start Year 1997
Number of shared co-authors 0
McGill University
Career Start Year 1994
Number of shared co-authors 0
University Medical Center Utrecht
Career Start Year 1991
Number of shared co-authors 11
Institute of Social and Preventive Medicine, University of Bern
Career Start Year 1990
Number of shared co-authors 1
Vanderbilt University Medical Center
Career Start Year 1982
Number of shared co-authors 1

Collaborators

Erasmus University Medical Center
Co-authored papers 17
University of Oxford
Co-authored papers 14
Erasmus University Medical Center
Co-authored papers 10
University of Oxford
Co-authored papers 9
American College of Medical Informatics, Department of Veteran Affairs, Harvard University T H Chan School of Public Health, Massachusetts Institute of Technology, The American Society for Clinical Investigation, University of Kentucky, Vanderbilt University Medical Center, Vanderbilt University Medical School
Co-authored papers 8
Columbia University
Co-authored papers 8
University of Dundee
Co-authored papers 8
University of California los angeles
Co-authored papers 8
University of Utah Health
Co-authored papers 8
University of Utah
Co-authored papers 8
Columbia University Irving Medical Center
Co-authored papers 8
University of Oxford
Co-authored papers 7
Co-authored papers 7
OHDSI Center at The Roux Institute, Northeastern University
Co-authored papers 6
Yonsei University College of Medicine
Co-authored papers 6
University of Gothenburg
Co-authored papers 6
Columbia University
Co-authored papers 6
University of California los angeles
Co-authored papers 5
Tufts, Tufts Medical Center
Co-authored papers 5
Janssen Pharmaceutical Research and Development
Co-authored papers 5
Quality Use of Medicines and Pharmacy Research Centre, University of South Australia
Co-authored papers 5
Ajou University Graduate School of Medicine
Co-authored papers 5
University of North Carolina at Chapel Hill
Co-authored papers 4
Erasmus University Medical Center
Co-authored papers 4
Columbia University Irving Medical Center
Co-authored papers 4
Riyadh Elm University
Co-authored papers 4
Janssen Pharmaceutical Research & Development
Co-authored papers 4
Erasmus University Medical Center
Co-authored papers 4
Instituto Carlos III
Co-authored papers 3
NMC Royal Hospital
Co-authored papers 3